CelLBxHealth’s product solutions enable specialised circulating tumour cell (CTC) enrichment and downstream analysis within your laboratory
We offer user-friendly systems, leveraging our patented Parsortix® platform for efficient harvesting of CTCs and CTC clusters, as well as immunofluorescence kits for easy, reliable downstream analysis
Parsortix platform and cassette
CelLBxHealth’s Parsortix platform is a unique CTC harvesting method using patented microfluidics in the form of a single use cassette, housed within an automated system.
Parsortix PR1 system
Gives translational researchers the power to capture and harvest circulating tumour and other cells of interest from 100 μL to 40 mL of blood, providing greater flexibility in downstream analysis.
For Research Use Only. Not For Use in Diagnostic Procedures.
Parsortix PR1 system
Gives translational researchers the power to capture and harvest circulating tumour and other cells of interest from 100 μL to 40 mL of blood, providing greater flexibility in downstream analysis.
For Research Use Only. Not For Use in Diagnostic Procedures.
Downstream analysis
CelLBxHealth’s CTC test kits provide advanced immunofluorescent staining of CTCs enriched from blood by the Parsortix platform.
Portrait® + CTC Staining kit
For Research Use Only. Not For Use in Diagnostic Procedures.
Enables the identification and enumeration of epithelial and mesenchymal cells including those undergoing epithelial-to-mesenchymal transition (EMT).
CellKeepTM Slide
For Research Use Only. Not For Use in Diagnostic Procedures.
Enhances retention & maintains the cellular morphology of circulating tumour cells (CTCs) harvested by the Parsortix platform.
Portrait® + CTC Staining kit
For Research Use Only. Not For Use in Diagnostic Procedures.
Enables the identification and enumeration of epithelial and mesenchymal cells including those undergoing epithelial-to-mesenchymal transition (EMT).
CellKeepTM Slide
For Research Use Only. Not For Use in Diagnostic Procedures.
Enhances retention & maintains the cellular morphology of circulating tumour cells (CTCs) harvested by the Parsortix platform.
An extension to your team
We will work with you to provide the best solution for your project to support the implementation of optimised workflows for efficient analysis and reproducible results.
Meet our Product Solutions team
Neil Darroch
Senior Sales Manager
Science has always been my passion. From my early years in school to my degree in Immunology from Glasgow University, learning about the latest advancements and breakthroughs in medical science has always made me optimistic for the future.
Knowing that I was not cut out for lab work then I have made it the focus of my career to find other ways to support scientific and medical advancement. From Customer Service roles to Technical Support roles, from Key Account Management to Sales Management and Business Development, supporting the scientific and medical community has always been my focus.
In the almost two decades since graduating from University I have worked for both large multinational research companies and small, start-up, medical diagnostic companies. It is the revolutionary potential of Liquid Biopsy to bring dramatic improvements to multiple stages of a cancer patients journey that attracted me to joining CelLBxHealth.
The wealth of information circulating tumour cells contain make them an ideal tool for understanding the metastatic process and translating these findings to actionable clinical tests.
Neil Darroch
Senior Sales Manager
Science has always been my passion. From my early years in school to my degree in Immunology from Glasgow University, learning about the latest advancements and breakthroughs in medical science has always made me optimistic for the future.
Knowing that I was not cut out for lab work then I have made it the focus of my career to find other ways to support scientific and medical advancement. From Customer Service roles to Technical Support roles, from Key Account Management to Sales Management and Business Development, supporting the scientific and medical community has always been my focus.
In the almost two decades since graduating from University I have worked for both large multinational research companies and small, start-up, medical diagnostic companies. It is the revolutionary potential of Liquid Biopsy to bring dramatic improvements to multiple stages of a cancer patients journey that attracted me to joining CelLBxHealth.
The wealth of information circulating tumour cells contain make them an ideal tool for understanding the metastatic process and translating these findings to actionable clinical tests.